Antioxidative properties of hydrogen sulfide may involve in its antiadhesive action on blood platelets

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1678-1682

  Morel, Agnieszka ^a   Malinowska, Joanna ^a   Olas, Beata ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Adhesion; Adhesive proteins; Blood platelets; Hydrogen sulfide

Indexed keywords

COLLAGEN; FIBRINOGEN; HYDROGEN SULFIDE; SODIUM HYDROSULFIDE; SUPEROXIDE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CELL STIMULATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; ANTIOXIDANTS; BLOOD PLATELETS; COLLAGEN; FIBRINOGEN; HUMANS; HYDROGEN SULFIDE; PLATELET ADHESIVENESS; SUPEROXIDES; TIME FACTORS; YOUNG ADULT;

EID: 84870679711     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.08.025     Document Type: Article

References (45)

1. Łowicka E., Bełtowski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007, 59:4-24.
2. Hughes M.N., Centelles M.N., Moore K.P. Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med 2009, 47:1346-1353.
3. Moore L., Li P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?. Trends Pharmacol Sci 2008, 29:84-90.
4. Whiteman M. Moore PK. Hydrogen sulphide and the vasculature: a novel vasculoprotective entity and regular of nitric oxide biovailability?. J Cell Mol Med 2009, 13:488-507.
5. Li L., Hsu A., Moore P.K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases!. Pharmacol Ther 2009, 123:386-400.
6. Qiao W., Chaoshu T., Hongfang J., Junbao D. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun 2010, 396:182-186.
7. Sun W.-H., Liu F.L., Chen Y., Zhu Y.Ch. Hydrogen sulphide decreases the level of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem Biophys Res Commun 2012, 421:164-169.
8. Wang R. Physiological implications of hydrogen sulphide: a whiff exploration that blossomed. Physiol Rev 2012, 92:791-896.
9. Liang GH, Xi Q, Leffler CW, Jaggar JH. Hydrogen sulfide activates Ca2+ sparks to induce cerebral arteriole dilation. J Physiol 2012;590:2709-20.
10. Zaicho N.V., Pentiuk O.O. Influence of hydrogen sulfide, dithionite, sulfite, thiosulfate and sulfate anions on human platelet aggregation. Ukr Biokhim Zh 2009, 81:105-113.
11. Truss N.J., Warner T.D. Gasotransmitters and platelets. Pharmacol Ther 2011, 132:196-203.
12. Predmore B.L., Lefer D.J. Development of hydrogen sulphide-based therapeutics for cardiovascular diseases. J Cardiovasc Transl Res 2010, 3:487-498.
13. Chuah S.C., Moore P.K., Zhu Y.Z. S-allylcysteine mediates cardioprotection on an acute myocardial infarction rat model via a hydrogen sulphide-mediated pathway. Am J Physiol Heart Circ Physiol 2007, 293:H2693-H2701.
14. Scharbert G., Kalb M.L., Duris M., Marschalak C., Kozek-Langenecker S.A. Garlic at dietary doses not impair platelet function. Anesth Analg 2007, 105:1214-1218.
15. Deplanecke B., Gaskins H.R. Hydrogen sulphide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003, 17:1310-1312.
16. Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001, 20:6008-6016.
17. Doolittle R.F., Schubert D., Schwartz S.A. Amino acid sequence studies on artiodactyl fibrinopeptides I Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys 1967, 118:456-467.
18. Wachowicz B., Kustroń J. Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios 1992, 70:41-47.
19. Walkowiak B., Michalak E., Koziołkiewicz W., Cierniewski C.S. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 1989, 56:763-766.
20. Tuszyński G.P., Murphy A. Spectrophotometric quantitation of anchorage - dependent cell numbers using the bicinchoninic acid protein assay reagent. Anal Biochem 1990, 184:189-191.
21. Jahn B., Hansch G.M. Oxygen radical generation in human platelets: dependence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol 1990, 93:73-79.
22. Olas B., Zbikowska H.M., Wachowicz B., Krajewski T., Buczyński A., Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol 1999, 46:961-966.
23. Wroblewski F., La Due J. Lactic dehydrogeanse activity in blood. Proc Soc Exp Biol Med 1955, 210:210-215.
24. Coughlin S.R. Protease-activated receptors in vascular biology. Thromb Haemost 2001, 86:298-307.
25. Vu T.K., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64:1057-1068.
26. Blockmans D., Deckmyn H., Vermylen J. Platelet activation. Blood Rev 1995, 9:143-156.
27. Kroll M.H., Schafer A.J. The analysis of ligand-receptor interaction in platelet activation. Immunopharmacology 1995, 29:31-65.
28. Levy-Toledano S. Platelet signal transduction pathways: could we organize them into a 'hierarchy'?. Haemostasis 1999, 29:4-15.
29. Ryningen A., Holmsen H. Biochemistry of platelet activation. Platelet Physiology and Pharmacology 1999, 1-22. Kluwer Academic Publishers, Norwell. H. Gundu, R. Rao (Eds.).
30. Peters R.J.G., Moons A.H.M. Platelet function and coronary artery disease. Eur J Clin Invest 2001, 31:3-5.
31. Zagli G., Patacchini R., Trevisani M., Abbate R., Cinotti S., Gensini G.F., et al. Hydrogen sulfide inhibits platelet aggregation. Eur J Pharmacol 2007, 559:65-68.
32. Essex D.W. The role of thiols and disulfides in platelet function. Antioxid Redox Signal 2004, 6:736-746.
33. Iuliano L., Colavita A.R., Leo R., Pratico D., Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997, 22:999-1006.
34. Wachowicz B., Olas B., Zbikowska H.M., Buczynski A. Generation of reactive oxygen species in blood platelets. Platelets 2002, 13:175-182.
35. Olas B., Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007, 23:1-11.
36. Pignatelli P., Pulcinelli F.M., Lenti L., Gazzaniga P.P., Violi F. Hydrogen peroxide is involved in collagen - induced platelet activation. Blood 1998, 91:484-490.
37. Yan S.K., Chang H., Wang L., Wu R., Wang Q.H. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006, 351:485-491.
38. Wu K. Platelet activation mechanisms and marker in arterial thrombosis. J Int Med 1996, 239:17-34.
39. Rittenhouse S.E. Phosphoinositide 3-kinase activation and platelet function. Blood 1996, 12:4401-4414.
40. Vemuri G.S., Zhang J., Keen J.H., Rittenhouse S.E. Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells. Biochem J 1996, 314:805-810.
41. Zhang J., Falck J.R., Reddy K.K., Abrams C.S., Zhao W., Rittenhouse S.E. Phosphatidyinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets. J Biol Chem 1995, 270:22807-22810.
42. Zhang J., Zhang J., Shattil S.J., Cunningham M.C., Rittenhouse S.E. Phosphoinositide 3-kinase γ and p85/phosphoinositide 3-kinase in platelets. J Biol Chem 1996, 271:6265-6272.
43. Haimovich B., Lipfert L., Brugge J.S., Shattil S.J. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J Biol Chem 1993, 268:15868-15877.
44. 3 -mediated pp125FAK phosphorylation and platelet spreading on fibrinogen are regulated by PI 3-kinase. BBA 1999, 1448:543-552.
45. Hu Y., Chen X., Pan T.T., Neo K.L., Lee S.W., Khin E.S., et al. Bian JS Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 2008, 455:607-616.